Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00818597

Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients (EISS-1)

PhaseI/II Study of the Safety and Efficacy of the Use of Granulocyte-Concentrates Applied in Extracorporeal Circulation Devices-the EISS-1 Study

Sponsor: University of Rostock

Conditions Severe Sepsis and Septic Shock

Interventions EISS

Updated 5 times since 2017 Last updated: Jan 6, 2009 Started: Dec 31, 2003 Primary completion: Apr 30, 2004 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00818597, this PHASE1/PHASE2 trial focuses on Severe Sepsis and Septic Shock and remains completed. Sponsored by University of Rostock, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Rostock

Data source: University of Rostock

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rostock, Germany